Uploads Contact
/
Login Upload

  • Search Results for 'Guidance Covid'

Uniform Guidance Crosswalk from Final Guidance to Existing Guidance A A A A A A
Uniform Guidance Crosswalk from Final Guidance to Existing Guidance A A A A A A
tatiana-dople
Guidance for Industry Developing Products for Weight Management DRAFT GUIDANCE This guidance
Guidance for Industry Developing Products for Weight Management DRAFT GUIDANCE This guidance
stefany-barnette
Guidance for Industry How to Comply with the Pediatric Research Equity Act DRAFT GUIDANCE
Guidance for Industry How to Comply with the Pediatric Research Equity Act DRAFT GUIDANCE
trish-goza
Guidance for Industry Concerns Related to the use of Clove Oil as an Anesthetic for Fish
Guidance for Industry Concerns Related to the use of Clove Oil as an Anesthetic for Fish
lindy-dunigan
Guidance for Industry Complicated Intra Abdominal Infections Developing Drugs for Treatment
Guidance for Industry Complicated Intra Abdominal Infections Developing Drugs for Treatment
kittie-lecroy
Guidance for Industry Applications for Premarket Review of New Tobacco Products DRAFT
Guidance for Industry Applications for Premarket Review of New Tobacco Products DRAFT
myesha-ticknor
Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs
Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs
pamella-moone
Guidance for Industry and FDA Staff Submissions for Postapproval Modifications to a Combination
Guidance for Industry and FDA Staff Submissions for Postapproval Modifications to a Combination
test
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE
Guidance for Industry ANDA Submissions Prior Approval Supplements Under GDUFA DRAFT GUIDANCE
conchita-marotz
Guidance for Industry Contract Manufacturing Arrangements for Drugs Quality Agreements
Guidance for Industry Contract Manufacturing Arrangements for Drugs Quality Agreements
tawny-fly
Informed Consent Information Sheet Guidance for IRBs Clinical Investigators and Sponsors
Informed Consent Information Sheet Guidance for IRBs Clinical Investigators and Sponsors
cheryl-pisano
Guidance for Industry Distributing Scientific and Medical Publications on Unapproved New
Guidance for Industry Distributing Scientific and Medical Publications on Unapproved New
calandra-battersby
Guidance for Industry Considerations for the Design of Early Phase Clinical Trials of
Guidance for Industry Considerations for the Design of Early Phase Clinical Trials of
briana-ranney
Guidance for Industry Safety Considerations for Container Labels and Carton Labeling
Guidance for Industry Safety Considerations for Container Labels and Carton Labeling
liane-varnes
ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits
ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits
pasty-toler
Guidance for Industry InternetSocial Media latforms with Character Space Limitations
Guidance for Industry InternetSocial Media latforms with Character Space Limitations
alida-meadow
Guidance for Industry Naming of Drug Products Containing Salt Drug Substances DRAFT GUIDANCE
Guidance for Industry Naming of Drug Products Containing Salt Drug Substances DRAFT GUIDANCE
karlyn-bohler
Guidance for Industry DirecttoConsumer Television Advertisements FDAAA DTC Television
Guidance for Industry DirecttoConsumer Television Advertisements FDAAA DTC Television
stefany-barnette
Guidance for Industry DirecttoConsumer Television Advertisements FDAAA DTC Television
Guidance for Industry DirecttoConsumer Television Advertisements FDAAA DTC Television
liane-varnes
Guidance for Industry Interim Product Reporting for Human Drug Compounding Outsourcing
Guidance for Industry Interim Product Reporting for Human Drug Compounding Outsourcing
giovanna-bartolotta
Implementing the Uniform Guidance
Implementing the Uniform Guidance
phoebe-click
stributed for comment purposes onlyComments and suggestions regarding
stributed for comment purposes onlyComments and suggestions regarding
natalia-silvester
COVID-19 SARS-CoV-2 Lisa Gilbert, MD, FAAFP,
COVID-19 SARS-CoV-2 Lisa Gilbert, MD, FAAFP,
mitsue-stanley
Guidance for Industry Assessment of Abuse Potential of Drugs DRAFT GUIDANCE This guidance
Guidance for Industry Assessment of Abuse Potential of Drugs DRAFT GUIDANCE This guidance
ellena-manuel